NCT03922542PHASE2, PHASE3Recruiting

Comparison of Standard vs. Accelerated Corneal Crosslinking

Price Vision Group

Start Date

4/16/2019

Completion Date

7/1/2026

Summary

The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.

Eligibility Criteria

Age Range: 10 years to No maximum

Inclusion Criteria: * Documented keratoconus or ectasia after refractive surgery Exclusion Criteria: * Insufficient corneal thickness * Ocular condition that may predispose the eye to complications * History of chemical injury or delayed epithelial healing * Condition that would interfere with or prolong epithelial healing * Known sensitivity to treatment medications * Pregnancy

Interventions

COMBINATION_PRODUCT

riboflavin 0.1%

COMBINATION_PRODUCT

Riboflavin 0.1%

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

KeratoconusEctasia Corneal

Locations

Price Vision Group

Indianapolis, Indiana 46260

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.